Form 8-K - Current report:
SEC Accession No. 0001828185-24-000060
Filing Date
2024-05-15
Accepted
2024-05-15 16:07:25
Documents
14
Period of Report
2024-05-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K brns-20240510.htm   iXBRL 8-K 43414
  Complete submission text file 0001828185-24-000060.txt   220575

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20240510.xsd EX-101.SCH 2759
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20240510_def.xml EX-101.DEF 16922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20240510_lab.xml EX-101.LAB 29996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20240510_pre.xml EX-101.PRE 17774
18 EXTRACTED XBRL INSTANCE DOCUMENT brns-20240510_htm.xml XML 4246
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 24950530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)